Quantum-Si (QSI) to Release Earnings on Tuesday

Quantum-Si (NASDAQ:QSI) is anticipated to issue its Q4 2025 results after the market closes on Tuesday, March 3rd. Analysts expect the company to announce earnings of ($0.14) per share and revenue of $0.7620 million for the quarter. Individuals can check the company’s upcoming Q4 2025 earning summary page for the latest details on the call scheduled for Tuesday, March 3, 2026 at 4:30 PM ET.

Quantum-Si Trading Down 3.1%

Shares of Quantum-Si stock opened at $0.91 on Tuesday. The business’s fifty day simple moving average is $1.15 and its 200 day simple moving average is $1.38. Quantum-Si has a 12 month low of $0.89 and a 12 month high of $3.10. The firm has a market capitalization of $196.51 million, a P/E ratio of -1.36 and a beta of 2.98.

Insider Transactions at Quantum-Si

In other Quantum-Si news, CEO Jeffrey Alan Hawkins sold 23,707 shares of the company’s stock in a transaction dated Monday, December 22nd. The shares were sold at an average price of $1.28, for a total transaction of $30,344.96. Following the sale, the chief executive officer directly owned 2,578,018 shares of the company’s stock, valued at $3,299,863.04. This represents a 0.91% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider John S. Vieceli sold 21,927 shares of the business’s stock in a transaction that occurred on Monday, December 22nd. The shares were sold at an average price of $1.28, for a total transaction of $28,066.56. Following the completion of the sale, the insider directly owned 800,973 shares in the company, valued at approximately $1,025,245.44. This trade represents a 2.66% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 54,261 shares of company stock worth $69,454 over the last 90 days. 22.95% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Quantum-Si

Several institutional investors have recently made changes to their positions in the stock. Vanguard Group Inc. boosted its holdings in shares of Quantum-Si by 0.5% in the third quarter. Vanguard Group Inc. now owns 8,714,507 shares of the company’s stock worth $12,287,000 after acquiring an additional 44,846 shares during the period. Geode Capital Management LLC lifted its holdings in Quantum-Si by 9.8% during the 4th quarter. Geode Capital Management LLC now owns 4,114,375 shares of the company’s stock worth $4,527,000 after purchasing an additional 367,206 shares in the last quarter. Millennium Management LLC bought a new position in Quantum-Si in the 1st quarter worth about $4,721,000. State Street Corp boosted its stake in Quantum-Si by 26.5% in the 4th quarter. State Street Corp now owns 3,562,721 shares of the company’s stock worth $3,919,000 after purchasing an additional 745,231 shares during the period. Finally, Squarepoint Ops LLC purchased a new position in Quantum-Si during the 3rd quarter valued at about $865,000. Hedge funds and other institutional investors own 39.90% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have recently commented on QSI. Weiss Ratings reiterated a “sell (d-)” rating on shares of Quantum-Si in a research note on Monday, December 29th. Canaccord Genuity Group dropped their target price on shares of Quantum-Si from $2.00 to $1.50 and set a “hold” rating on the stock in a research note on Monday, December 22nd. Two research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $3.55.

About Quantum-Si

Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods.

Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.